| Symbol | KRTL |
|---|---|
| Name | KRTL HOLDING GROUP, INC |
| Sector | UNDEFINED |
| Region | North America |
| Industry | - |
| Address | 80401 United States CO 14143 Denver W Parkway Suite 100 |
| Telephone | +1 8056660387 |
| Fax | — |
| — | |
| Website | http://www.krtlholding.com |
| Incorporation | US |
| Incorporated On | 1984 |
| Employees | — |
| Fiscal Year | 12/31 |
| Public Since | — |
| Exchanges | OTC |
| Auditor | Aloba, Awomolo & Partners; |
| Audit Status | UNAUDITED |
| Reporting Status | Alternative Reporting Standard |
| CIK | 0001288614 |
| Description | KRTL Holding Group (OTC: KRTL) serves as the parent company, providing strategic oversight and ensuring synergy among its subsidiaries. The groups mission is to integrate innovation, regulatory excellence, and market expertise to deliver comprehensive solutions and drive sustainable growth. KRTL Biotech Inc, a wholly owned subsidiary of KRTL Holding Group (OTC: KRTL) and an FDA-registered pharmaceutical company, is dedicated to advancing biotechnology research and development. The company partners with cGMP manufacturers, ISO-certified laboratories, and academic institutions to foster innovation and deliver solutions across various sectors. Its commitment to quality and compliance makes it the foundation of KRTLs operations and a leader in cutting-edge biotechnology.. KRTL International Inc, a wholly owned subsidiary of KRTL Holding Group (OTC: KRTL), is the distribution and consulting arm of the group. It bridges the gap between innovation and global markets by providing expert consulting services, strategic market analysis, and efficient distribution systems. This subsidiary ensures that KRTLs products and solutions are tailored to client needs and delivered seamlessly worldwide. Additional info from OTC: |
No news found.